The trial will aim to enrol 640 healthy adults, aged 50- to 70-years-old

Positive results revealed from two Phase III trials of potential asthma therapy

Rilzabrutinib missed primary and secondary endpoints as a treatment for pemphigus

Consultation will also ask for views on whether flu vaccines should be a requirement for health and care […]

Scientists from Nanyang Technological University, Singapore (NTU Singapore), in collaboration with clinicians at Tan Tock Seng Hospital (TTSH) […]

Researchers from Southern University of Science and Technology in Shenzhen show that nanofibers are superb at capturing droplets […]

Updated Date: Wed, 01 Sep 2021 00:00:00 EDT

Updated Date: Wed, 01 Sep 2021 00:00:00 EDT

Updated Date: Wed, 01 Sep 2021 00:00:00 EDT

No joy for Ajovy: Teva’s migraine drug can’t find a win in meta-analysis versus Biohaven, AbbVie meds nhigginsdunn […]